248 related articles for article (PubMed ID: 9626568)
21. Nicotine-enhanced oxidation of low-density lipoprotein and its components by myeloperoxidase/H₂O₂/Cl- system.
Oliveira OM; Brunetti IL; Khalil NM
An Acad Bras Cienc; 2015 Mar; 87(1):183-92. PubMed ID: 25806984
[TBL] [Abstract][Full Text] [Related]
22. The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids.
Spickett CM; Jerlich A; Panasenko OM; Arnhold J; Pitt AR; Stelmaszyńska T; Schaur RJ
Acta Biochim Pol; 2000; 47(4):889-99. PubMed ID: 11996112
[TBL] [Abstract][Full Text] [Related]
23. p-Hydroxyphenylacetaldehyde, the major product of tyrosine oxidation by the activated myeloperoxidase system can act as an antioxidant in LDL.
Exner M; Alt E; Hermann M; Hofbauer R; Kapiotis S; Quehenberger P; Speiser W; Minar E; Gmeiner B
FEBS Lett; 2001 Feb; 490(1-2):28-31. PubMed ID: 11172805
[TBL] [Abstract][Full Text] [Related]
24. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
Hazen SL; Heinecke JW
J Clin Invest; 1997 May; 99(9):2075-81. PubMed ID: 9151778
[TBL] [Abstract][Full Text] [Related]
25. Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction.
Abdo AI; Rayner BS; van Reyk DM; Hawkins CL
Redox Biol; 2017 Oct; 13():623-632. PubMed ID: 28818791
[TBL] [Abstract][Full Text] [Related]
26. Comparison between copper-mediated and hypochlorite-mediated modifications of human low density lipoproteins evaluated by protein carbonyl formation.
Yan LJ; Lodge JK; Traber MG; Matsugo S; Packer L
J Lipid Res; 1997 May; 38(5):992-1001. PubMed ID: 9186916
[TBL] [Abstract][Full Text] [Related]
27. Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro.
Marsche G; Furtmüller PG; Obinger C; Sattler W; Malle E
Cardiovasc Res; 2008 Jul; 79(1):187-94. PubMed ID: 18296711
[TBL] [Abstract][Full Text] [Related]
28. Hemoglobin induced apolipoprotein B crosslinking in low-density lipoprotein peroxidation.
Miller YI; Felikman Y; Shaklai N
Arch Biochem Biophys; 1996 Feb; 326(2):252-60. PubMed ID: 8611031
[TBL] [Abstract][Full Text] [Related]
29. Entire Peroxidation Reaction System of Myeloperoxidase Correlates with Progressive Low-Density Lipoprotein Modifications via Reactive Aldehydes in Atherosclerotic Patients with Hypertension.
Liu Q; Liu Y; Shi J; Gao M; Liu Y; Cong Y; Li Y; Wang Y; Yu M; Lu Y; Wang D; Chen S; Zheng Y; Cheng Y
Cell Physiol Biochem; 2018; 50(4):1245-1254. PubMed ID: 30355911
[TBL] [Abstract][Full Text] [Related]
30. Effects of oxidation on the structure and stability of human low-density lipoprotein.
Jayaraman S; Gantz DL; Gursky O
Biochemistry; 2007 May; 46(19):5790-7. PubMed ID: 17444660
[TBL] [Abstract][Full Text] [Related]
31. Structural and functional properties of apolipoprotein B in chemically modified low density lipoproteins.
Vanderyse L; Devreese AM; Baert J; Vanloo B; Lins L; Ruysschaert JM; Rosseneu M
Atherosclerosis; 1992 Dec; 97(2-3):187-99. PubMed ID: 1466663
[TBL] [Abstract][Full Text] [Related]
32. The mechanism of the hypochlorite-induced lipid peroxidation.
Panasenko OM
Biofactors; 1997; 6(2):181-90. PubMed ID: 9260000
[TBL] [Abstract][Full Text] [Related]
33. Hypochlorous acid and human blood low density lipoproteins modified by hypochlorous acid increase erythrocyte adhesion to endothelial cells.
Gorbatenkova EA; Artmann GM; Panasenko OM
Membr Cell Biol; 2000; 13(4):537-46. PubMed ID: 10926371
[TBL] [Abstract][Full Text] [Related]
34. Role of Myeloperoxidase Oxidants in the Modulation of Cellular Lysosomal Enzyme Function: A Contributing Factor to Macrophage Dysfunction in Atherosclerosis?
Ismael FO; Barrett TJ; Sheipouri D; Brown BE; Davies MJ; Hawkins CL
PLoS One; 2016; 11(12):e0168844. PubMed ID: 27997605
[TBL] [Abstract][Full Text] [Related]
35. Identification of modified tryptophan residues in apolipoprotein B-100 derived from copper ion-oxidized low-density lipoprotein.
Yang C; Gu ZW; Yang M; Lin SN; Siuzdak G; Smith CV
Biochemistry; 1999 Nov; 38(48):15903-8. PubMed ID: 10625456
[TBL] [Abstract][Full Text] [Related]
36. Dynamics of the oxidation of low density lipoprotein induced by free radicals.
Noguchi N; Gotoh N; Niki E
Biochim Biophys Acta; 1993 Jul; 1168(3):348-57. PubMed ID: 8323975
[TBL] [Abstract][Full Text] [Related]
37. Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl.
Laggner H; Muellner MK; Schreier S; Sturm B; Hermann M; Exner M; Gmeiner BM; Kapiotis S
Free Radic Res; 2007 Jul; 41(7):741-7. PubMed ID: 17577734
[TBL] [Abstract][Full Text] [Related]
38. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M
Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320
[TBL] [Abstract][Full Text] [Related]
39. Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100.
Delporte C; Boudjeltia KZ; Noyon C; Furtmüller PG; Nuyens V; Slomianny MC; Madhoun P; Desmet JM; Raynal P; Dufour D; Koyani CN; Reyé F; Rousseau A; Vanhaeverbeek M; Ducobu J; Michalski JC; Nève J; Vanhamme L; Obinger C; Malle E; Van Antwerpen P
J Lipid Res; 2014 Apr; 55(4):747-57. PubMed ID: 24534704
[TBL] [Abstract][Full Text] [Related]
40. Myeloperoxidase acts as a source of free iron during steady-state catalysis by a feedback inhibitory pathway.
Maitra D; Shaeib F; Abdulhamid I; Abdulridha RM; Saed GM; Diamond MP; Pennathur S; Abu-Soud HM
Free Radic Biol Med; 2013 Oct; 63():90-8. PubMed ID: 23624305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
